These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3827114)

  • 21. Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
    Conti F; Borrelli O; Anania C; Marocchi E; Romeo EF; Paganelli M; Valesini G; Cucchiara S
    Dig Liver Dis; 2005 Oct; 37(10):761-7. PubMed ID: 16024303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
    Lemberg DA; Clarkson CM; Bohane TD; Day AS
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy trends in the prevention of radiation-induced diarrhea after pelvic and abdominal irradiation. Results of a tricenter study].
    Hombrink J; Voss AC; Fröhlich D; Glatzel M; Krauss A; Glaser FH
    Strahlenther Onkol; 1995 Jan; 171(1):49-53. PubMed ID: 7839305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of Kaologeais and Smectite in the treatment of colopathies].
    Dietsch R; Bonneville B
    Med Chir Dig; 1981; 10(6):549-51. PubMed ID: 7311645
    [No Abstract]   [Full Text] [Related]  

  • 25. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisapride for the treatment of constipation in children.
    Bhatnagar SK
    Indian Pediatr; 2000 Aug; 37(8):917-8. PubMed ID: 10951653
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of rectoscopy in the diagnosis of Schistosoma mansoni bilharziasis. Study at Nkolbisson-Cameroon].
    Biwole Sida M; Essame Oyono JL; Amvene N; Kouemeni L; Hagbe P; Same Ekobo A; Minkala M; Edzoa T
    Med Trop (Mars); 1993; 53(2):219-24. PubMed ID: 8412593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative method of estimating inflammation in the rectal mucosa. II. Normal limits in symptomatic patients.
    Rubio CA; Johansson C; Kock Y
    Scand J Gastroenterol; 1982 Nov; 17(8):1077-81. PubMed ID: 7167738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intestinal mucosa protection of muscovite n ulcerative colitis in rats].
    Wang LJ; Chen SJ; Si JM
    Zhongguo Zhong Yao Za Zhi; 2005 Dec; 30(23):1840-4. PubMed ID: 16499023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis.
    Miele E; Pascarella F; Quaglietta L; Giannetti E; Greco L; Troncone R; Staiano A
    Aliment Pharmacol Ther; 2007 Apr; 25(8):933-9. PubMed ID: 17402997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of chronic post-radiation proctitis with oral administration of sucralfate.
    Sasai T; Hiraishi H; Suzuki Y; Masuyama H; Ishida M; Terano A
    Am J Gastroenterol; 1998 Sep; 93(9):1593-5. PubMed ID: 9732960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of attapulgite associated with guar gum in the treatment of colitis and colopathy].
    Leymarios J
    Therapeutique; 1970 May; 46():21-2. PubMed ID: 5427182
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
    Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
    Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of smectite on the changes in gastric potential difference induced by aspirin in man].
    Dahan R; Schatz B; Isal JP; Caulin C
    Gastroenterol Clin Biol; 1984 Nov; 8(11):878-9. PubMed ID: 6526247
    [No Abstract]   [Full Text] [Related]  

  • 37. [HEALTH-IMPROVING REMEDIES ON THE BASIS OF SMECTITE®].
    Shirobokov V; Yankovskii D; Dyment G
    Lik Sprava; 2015; (1-2):3-9. PubMed ID: 26118019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the effects of smectite on the concentration of expired hydrogen].
    Frexinos J; Suduca JM; Schatz B
    Gastroenterol Clin Biol; 1986; 10(6-7):526-7. PubMed ID: 3758600
    [No Abstract]   [Full Text] [Related]  

  • 39. Does smectite have antidiarrheal activity?
    Pierce N; Fontaine O
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):505-6. PubMed ID: 8071793
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions between smectite, a mucus stabilizer, and acidic and basic drugs. In vitro and in vivo studies.
    Albengres E; Urien S; Tillement JP; Oury P; Decourt S; Flouvat B; Drieu K
    Eur J Clin Pharmacol; 1985; 28(5):601-5. PubMed ID: 3899678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.